🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
TNY
$TNYA
🔒 US EquitiesTenaya Therapeutics Inc
AVG HISTORICAL GAP
+0.84%
MAX GAP RECORD
-6.25%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $TNYA
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$TNYA
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Aug 12, 2026 Earnings Release 2026-08-12 (BEFORE OPEN) |
+2.00%
|
| May 13, 2026 Earnings Release 2026-05-13 (AFTER CLOSE) |
+0.00%
|
| Mar 11, 2026 Earnings Release 2026-03-11 (AFTER CLOSE) |
-1.05%
|
| Nov 10, 2025 Earnings Release 2025-11-10 (BEFORE OPEN) |
-6.25%
|
| Aug 06, 2025 Earnings Release 2025-08-06 (AFTER CLOSE) |
+0.74%
|
| May 07, 2025 Earnings Release 2025-05-07 (AFTER CLOSE) |
+1.11%
|
| Mar 10, 2025 Earnings Release 2025-03-10 (AFTER CLOSE) |
+2.37%
|
| Nov 06, 2024 Earnings Release 2024-11-06 (AFTER CLOSE) |
+4.93%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
2.8%
Bullish Gaps (9)
Bearish Gaps (3)
Neutral / Flat (2)
📖 Intelligence Summary
Tenaya Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics for cardiovascular diseases. Its programs include TN-201, TN-401, and TN-301. The company was founded by Deepak Srivastava, Benoit G. Bruneau, Bruce R. Conklin, Sheng Ding, Saptarsi Haldar, and Eric Newell Olson in 2016 and is headquartered…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗